Graypoint LLC Takes $1.16 Million Position in Option Care Health, Inc. (NASDAQ:OPCH)

Graypoint LLC acquired a new stake in Option Care Health, Inc. (NASDAQ:OPCH) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 50,035 shares of the company’s stock, valued at approximately $1,161,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Wellington Management Group LLP increased its position in shares of Option Care Health by 15.5% in the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock valued at $310,650,000 after buying an additional 1,328,326 shares in the last quarter. FMR LLC boosted its stake in shares of Option Care Health by 134.0% in the third quarter. FMR LLC now owns 7,516,448 shares of the company’s stock worth $235,265,000 after acquiring an additional 4,304,896 shares during the last quarter. Westfield Capital Management Co. LP boosted its stake in shares of Option Care Health by 10.2% in the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after acquiring an additional 599,589 shares during the last quarter. State Street Corp boosted its stake in shares of Option Care Health by 1.4% in the third quarter. State Street Corp now owns 6,257,172 shares of the company’s stock worth $195,849,000 after acquiring an additional 83,395 shares during the last quarter. Finally, Thrivent Financial for Lutherans boosted its stake in shares of Option Care Health by 7.4% in the third quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock worth $183,541,000 after acquiring an additional 404,811 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on OPCH. The Goldman Sachs Group lowered Option Care Health from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 price target (down from $31.00) on shares of Option Care Health in a research note on Friday. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and lowered their price target for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. UBS Group assumed coverage on Option Care Health in a research note on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective on the stock. Finally, Barrington Research dropped their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a report on Thursday, October 31st. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, Option Care Health currently has a consensus rating of “Hold” and an average target price of $29.14.

Option Care Health Stock Down 0.6 %

Shares of NASDAQ:OPCH opened at $23.99 on Friday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The business has a fifty day moving average of $23.10 and a two-hundred day moving average of $27.70. The stock has a market cap of $4.08 billion, a P/E ratio of 20.16, a PEG ratio of 2.43 and a beta of 1.31. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $34.63.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the stock in a transaction dated Friday, November 8th. The stock was acquired at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.64% of the company’s stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.